Skip to content

University of Copenhagen aims to prevent early aging through new artificial intelligence research collaboration

08.08.2017  10:38
University of Copenhagen has joined forces with the American artificial intelligence company Insilico Medicine to develop drugs that prevent premature aging.

The purpose of the new research partnership is to use artificial intelligence (AI) to find molecules that can be used in the development of drugs against age-related diseases such as Alzheimer's, Parkinson's and cardiovascular diseases.

Such diseases are caused by mutations in the genes that repair DNA causing early aging. If the collaboration is successful, the researchers will find molecules that can repair DNA and thereby increase the health span globally.

The research collaboration will make use of artificial intelligence algorithms to study the aging processes and discover new interventions in aging. They make use of a specific type of AI, which can discover which molecules can stimulate DNA repair. At the advanced laboratories at University of Copenhagen, the researchers will be able to test the molecules to select the most effective ones for producing new medicine.

Read more here.